Abstract

The distribution, retention, and excretion of intravenously injected /sup 241/Am citrate have been investigated in a nonhuman primate. Seven adult female Kenya baboons which had been given 0.2 ..mu..Ci/kg were studied for 817 days by a combination of techniques: (a) external counting of 60-keV ..gamma.. of /sup 241/Am in vivo in both whole-body and partial-body geometries, (b) bioassay of liver and skull biopsy samples, and (c) radioanalysis of /sup 241/Am in excreta and baboon tissues at sacrifice. The data thus far confirm previously reported results that the major initial deposition sites of soluble /sup 241/Am in the baboon are the skeleton (35% of the injected dose (percentage ID) at 1 day) and liver (31% ID at 1 day). The elimination rate of /sup 241/Am from the liver was fairly rapid at 2.5%/day (T/sub 1/2/ = 28 days), whereas the retention of /sup 241/Am in bone was long (at least several years). Americium-241 excreted during the first week after injection was detected principally in the urine, whereas the majority of Am excreted during the following 7 weeks was in feces, corresponding in the most part to elimination of Am from the liver. Microlocalization of Am in various soft tissues indicates generalmore » agreement with results previously reported for other species. However, americium in the baboon ovary at late times after injection is found as highly focalized sources, occurring principally in the outer cortical regions and associated with concretic structures. The implications of the findings of these studies with respect to metabolic parameters used for radiation dose calculations in man are discussed.« less

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.